Skip to main content

ORIGINAL RESEARCH article

Front. Neurosci., 09 January 2024
Sec. Visual Neuroscience
This article is part of the Research Topic Multimodal Perceiving Technologies in Neuroscience and Vision Applications View all 3 articles

3.0 T multi-parametric MRI reveals metabolic and microstructural abnormalities in the posterior visual pathways in patients with thyroid eye disease

  • 1Radiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong Province, China
  • 2Radiology Department, Huizhou Central People’s Hospital, Huizhou, Guangdong Province, China
  • 3Endocrinology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong Province, China

Introduction: We aim to explore the microstructural and metabolic changes in visual pathways in patients with thyroid eye disease (TED) using 3T multi-parametric MRI.

Methods: Thirty-four TED patients (inactive group = 20; active group = 14; acute group = 18; chronic group = 16) and 12 healthy controls (HC) were recruited from November 2020 to July 2021. Proton magnetic resonance spectroscopy (1H-MRS), glutamate chemical exchange saturation transfer (GluCEST) and diffusion kurtosis imaging (DKI) were performed on 3.0T MR scanner. Data analysis and group comparisons were performed after MR data processing.

Results: As compare to HC group, the levels of total choline (tCh) in optic radiation (OR) in active group ([1.404 ± 0.560] vs. [1.022 ± 0.260]; p < 0.05), together with tCh ([1.415 ± 0.507] vs. [1.022 ± 0.260]; p < 0.05) in OR in acute group were significantly increased. Glutamine (Gln) levels were higher in OR in the chronic group than those in HCs and were positively correlated with the levels of thyroglobulin antibody (TgAb), thyroid peroxidase antibody (TPOAb), free triiodothyronine (FT3) and FT4 in chronic group. Glutamate (Glu) levels by 1H-MRS did not show significant differences between any two groups. Interestingly, MTRasym (3.0 ppm) was higher in OL in inactive group, active group, acute group and chronic group than those in HCs, and was positively correlated with Glu levels in OL in 1H-MRS. Fractional anisotropy (FA) values from DKI in OR in acute group were significantly lower than those in HCs.

Discussion: Our initial study demonstrate that GluCEST performs better than 1H-MRS to monitor Glu alterations in visual pathway in TED patients. Changes of brain glutamine levels in TED patients are closely related to their associated hormones alterations, indicating that disease injury status could be reflected through non-invasive metabolites detection by brain 1H-MRS. FA is the most sensitive DKI index to reveal the visual pathway impairment in TED patients. Altogether, our study revealed that 3T multiparametric MR techniques are useful to demonstrate metabolic and microstructural alterations in visual pathways in TED patients. We found that damage to visual pathways occurs in mild TED cases, which not only offers a new approach to the diagnosis of dysthyroid optic neuropathy, but also demonstrates neuropathy in TED is a gradual and continuous spatio-emporal progression.

Introduction

Thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy (TAO) or Graves’ orbitopathy, is a complex autoimmune disease that mainly presents with ocular changes, leading to a significant reduction in patients’ quality of life and psychological health, with the worst cases showing dysthyroid optic neuropathy (DON) (Riguetto et al., 2019; Taylor et al., 2020). Pathological evaluations of TED patients include extraocular muscle destruction, various pro-inflammatory factors and lymphocyte infiltration (Smith and Hegedüs, 2016). Many previous studies based on optical coherence tomography and 3 T brain magnetic resonance imaging (MRI) showed that damage to the optic nerve could be transmitted along the visual pathway to the visual radiation and the occipital lobe (Tur et al., 2016). Currently, by the use of Ultrasound, ophthalmoscope and optical coherence tomography techniques, clinical visual detection is subjective and lacks precision to assess the onset of DON (Zhang et al., 2019; Ji et al., 2021; Zhang et al., 2021). Therefore, it is essential to find a simple, non-invasive and effective technique to assess the status of intracranial visual pathway in TED patients.

More and more people show interest in DON research, for visual impairment in thyroid-related eye disease is a critical event that affects treatment options (Garip-Kuebler et al., 2021; Ji et al., 2021). However, the diagnosis of DON is mainly through abnormal visual function and gross anatomy. We do not exactly know when the optic nerve injury occurs. At present, conventional MRI diagnosis of TED is mainly focused on the observation of the extraocular muscle hypertrophy and optic nerve stretching (Rutkowska-Hinc et al., 2018), which is limited to the anatomical changes of intraorbital lesions. Diffusion tensor imaging (DTI) has been performed to study microstructural changes of the optic nerve in severe TED patients (Lee et al., 2018; Chen et al., 2020), which indicated that MD (mean diffusivity), AD (axial diffusivity) and RD (radial diffusivity) were significantly lower in TED patients than those in healthy controls. Diffusion kurtosis imaging (DKI), as a direct extension of the DTI model for a non-Gaussian distribution (Xu et al., 2018; Li et al., 2020), has been shown to better characterize the microstructural alterations of the brain, but recently there are no relevant reports of DKI in TED patients. In vivo proton MR Spectroscopy (1H-MRS) provides a simple, efficient and inexpensive technical support for detecting the molecular and biochemical information of the brain. Elberling and Danielsen et al. has studied the metabolic changes by 1H-MRS in parietal-occipital lobe in patients with acute thyrotoxic graves disease before and after treatment, and found that glutamine levels were consistently significantly reduced in parietal-occipital lobe (Elberling et al., 2003). The glutamate (Glu) levels can be measured by 1H-MRS and chemical exchange saturation transfer (CEST), the latter is a relatively new and promising MRI contrast technique which can efficiently investigate changes in proteins, neurotransmitters and other metabolites (Mehrabian et al., 2017). More importantly, GluCEST can produce high-resolution images covering large areas of the brain (Sydnor et al., 2021), compared to traditional 1H-MRS. So far, there are no reports on GluCEST to study the changes of exchange rate between Glu and water in the visual pathway with TED involving the intraorbital region.

Given that it is not clear whether there are metabolic and microstructural alterations in intracranial visual pathway in TED patients, and multi-parametric MRI has advantages in diagnosing and assessing intracranial changes compared with any other radiological technique. Hence, this study aimed to explore the metabolic and microstructural changes in visual pathways in TED patients by using 1H-MRS, GluCEST and DKI, which were expected to provide objective references for TED patients before the onset of disabling DON.

Materials and methods

Participants

The study was approved by the Ethics Committee. Informed consent was obtained from the TED patients before MRI examinations. Thirty-four patients underwent magnetic resonance scans from November 2020 to July 2021. A clinical diagnosis of TED was made if the examination showed that thyroid dysfunction or dysregulation was objectively correlated with ocular symptoms. Ocular symptoms include minor lid retraction (<2 mm), mild soft-tissue involvement, exophthalmos <3 mm above normal for ethnicity and sex, no or intermittent diplopia, and corneal exposure responsive to lubricants. Patients were eligible for inclusion in this study if they were 18 to 70 years of age. The exclusion criteria were as follows: (1) mental illness; (2) other neurological conditions, including brain tumor, cerebral infarction or hemorrhage, brain trauma, and degeneration injury; (3) other conditions that may cause unilateral or bilateral exophthalmos or extraocular muscle enlargement, such as Cushing’s syndrome, orbital pseudotumor, idiopathic myositis, and cellulitis; (4) visual loss. 16 cases are in the exclusion criteria. Activity measures were based on the following classic features of inflammation constituting the clinical activity score (CAS): (1) spontaneous retrobulbar pain; (2) pain on attempted up, down, or side gaze; (3) redness of the eyelids; (4) redness of the conjunctiva; (5) swelling of the eyelids; (6) swelling of the caruncle, plica, or both; (7) chemosis and the presence of more than three features indicating active TED. Acute and chronic conditions were determined based on whether the disease duration was >6 months (inactive group = 20; active group = 14; acute group = 18; chronic group = 16). Healthy age- and sex-matched controls (HCs, n = 12) were recruited.

Magnetic resonance imaging

Magnetic resonance spectroscopy

All participants underwent T1 fluid-attenuated inversion recovery (T1-FLAIR) imaging and 1H-MRS using a 3 T General Electric MR Scanner (Sigma; GE Healthcare, Milwaukee, WI, USA). T1-FLAIR images acquired with the following parameters: repetition time [TR], 1750 ms; echo time [TE], 24 ms; inversion time [TI], 780 ms; matrix, 320 × 224; and field of view [FOV], 24 × 24 cm, were used for anatomical localization. Multivoxel spectral data were obtained at 8 min and 12 s upon applying water-suppressed point-resolved spectroscopy (PRESS) pulse sequence (TR, 3500 ms; TE, 29 ms; FOV, 16 cm × 16 cm; matrix size, 11 × 11; slice thickness, 5 mm; FWHM<20hz; number of repeated acquisitions = 1; water suppression method: Chemical shift selective (CHESS) pulse; voxel size = 7.5*4 cm). The entire voxel was located in the OR and the occipital cortex of the brain, shown in Figure 1. Data post-processing and quantification were analyzed using LCModel (version 6.3). The Cramer-Rao lower bounds of all metabolite to be analyzed <15%. On axial T1-FLAIR images, a line was made between the zygomatic process on both sides, and the vertical distance between the front of the eyeball and the line was measured, which is exophthalmic extent. Blood tests were taken three days before or after the MRI.

FIGURE 1
www.frontiersin.org

Figure 1. Representative MRS spectrum. The ROI is shown in an axial T1 fluid-attenuated inversion recovery (T1FLAIR) image. (A): right optic radiation (ROR), (B): right occipital lobe (ROL), (C): left optic radiation (LOR), (D): left occipital lobe (LOL). MI, MyoInositol; Ch, Choline-containing Compounds; Cr, Creatine; NAA, N-Acetylaspartate; Glx, Glutamate + Glutamine.

GluCEST

Gradient echo MRI sequence with magnetization transfer (MT) was used for CEST imaging (TR, 50 ms; TE, 3.1 ms; FOV, 24 cm × 24 cm; matrix, 128 × 128; slice thickness, 5 mm; bandwidth, 15.63 kHz; flip angle, 60°). The MT saturation pulse was a Fermi pulse with a width of 4 ms and B1 of 0.2 μT. The scan yielded 2 equidistant frequency shifts (−3 to 3 ppm) and an extra S0 image. Image processing and data analysis were performed using MATLAB custom scripts (The Mathworks, Inc., Natick, MA, United States) (Mao et al., 2019; Tang et al., 2020). In the previous study, the Z-spectra show that the amine protons on Glu generated a CEST effect with a chemical shift of 3.0 ppm away from bulk water, and indicate that the GluCEST signal was concentration-dependent (Jia et al., 2020). Figure 2 showed the GluCEST contrast plot, also known as the magnetization transfer ratio (MTRasym). MTRasymcalculated as,

FIGURE 2
www.frontiersin.org

Figure 2. GluCEST% maps of different groups. (A,D): healthy control, (B): chronic group, (C): acute group, (E): inactive group, (F): active group. 1, 2: optic radiation (OR), 3, 4: occipital lobe (OL).

MTRasym = [S (−3 ppm) – S (+3 ppm)]/S0.

where S (−3 ppm) and S (+3 ppm) were the water signals of the saturation pulse at an offset of ±3 ppm against the water resonance, respectively, and S0 was the signal for water without a saturated pulse.

Diffusion kurtosis imaging

The DKI scan was obtained using echo-planar imaging sequence (TR, 6000 ms; TE, 73.4 ms; FOV, 24 cm × 24 cm; matrix, 224 × 384; thickness, 5.0 mm; interslice gap, 5.0 mm; a number of slices, 20). Three b-values (0, 1,000, and 2,000 s/mm2) were applied in 15 directions, with a total acquisition time of 3 min and 5 s (Guan et al., 2019). The raw data (DICOM format) was sent to commercial workstations (GE, ADW 45, Rue de la Miniere, France) equipped with Functool software. The DKI and T1-FLAIR images were opened at the same time on the workstations, and after double magnification, the area of interest is drawn on the T1-FLAIR image at the chiasmatic - optic radiation-occipital lobe level by a neuro-radiologists after one-year training to obtain mean diffusivity (MD), axial diffusivity (Da), radial diffusivity (Dr), fractional anisotropy (FA), mean kurtosis (MK), axial kurtosis (Ka), and radial kurtosis (Kr) parameter maps. The regions of interest in the OR and occipital cortex were independently drawn as a fixed-size (10–20 mm2) ellipse, as shown in Figure 3.

FIGURE 3
www.frontiersin.org

Figure 3. Representative region of interest (ROI) for DKI parameters. (A): The raw map of DKI, (B): MD map, (C): FA map, (D): Da map, (E): Dr. map, (F): MK map, (G): Ka map, (H): Kr map, 1, 2: optic radiation (OR), 3, 4: occipital lobe (OL).

Statistical analysis

All data were analyzed using SPSS 25 statistical software (version 24, IBM Corp., Armonk, NY, United States). Normality test and variance homogeneity test were performed first for the three groups of data (1H-MRS, DKI parameters, GluCEST and age). If the three groups of data conform to normal distribution, One-way Analysis of Variance (ANOVA) was used to compare the differences of the three group. LSD (least significant difference) test was used for comparison between groups. If the variance of individual parameters was uneven or did not conform to normal distribution, Kruskal-Wallis rank sum test was applied to analyze the differences between groups. Chi-square (χ2) tests were used to compare sex between the TED groups and HCs. Two-sided p-values less than 0.05 indicated statistical significance. The relationships between metabolite concentrations and serum indices were analyzed using Spearman’s correlation coefficient. All numerical data were averaged and reported as mean ± standard deviation.

Results

Demographics and clinical characteristics

Compared with HCs, significant differences in proptosis were seen in both active TED groupand chronic TED group, but not in inactive and acute TED group. There were no significant differences in age and sex between the active, inactive, and HC group and between the acute, chronic, and HC group. In addition, no significant differences were seen in FT3, FT4, TSH, TRAb, TPOAb and TgAb between inactive and active group, and between chronic and acute group. All study subjects did not present with disabling dysthyroid optic neuropathy confirmed by clinical evaluation. Table 1 showed the patients’ demographics and clinical characteristics.

TABLE 1
www.frontiersin.org

Table 1. Clinical features and demographic information between TED groups and HCs.

Metabolic alterations in TED patients by 1H-MRS

As can be seen in Table 2, the levels of total choline (tCh) in OR in active group were significantly higher, compared with HCs ([1.404 ± 0.560] vs. [1.022 ± 0.260]; p < 0.05) (The unit of metabolites in MRS is in an arbitrary unit). Compared with HC group, the amounts of glutamine (Gln) ([3.014 ± 2.929] vs. [1.035 ± 1.043]) in OR in chronic group, together with those of tCh ([1.415 ± 0.507] vs. [1.022 ± 0.260]) in OR in acute group were significantly higher (p < 0.05). There were no significant differences in Glu levels between any two groups, but a tendency increase was shown in TED groups compared to HCs.

TABLE 2
www.frontiersin.org

Table 2. Value of FA in the different groups and locations.

Metabolic alterations in TED patients by GluCEST

As was shown in Figure 4, the GluCEST effect in OR in inactive group relative to HCs ([0.008 ± 0.023] vs. [−0.002 ± 0.013]) were significantly higher (p < 0.05). Meanwhile, the GluCEST effect in OL in inactive, active, chronic and acute groups as compared to HCs ([0.002 ± 0.010] vs. [−0.006 ± 0.009], [0.007 ± 0.013] vs. [−0.006 ± 0.009], [0.002 ± 0.010] vs. [−0.006 ± 0.009], [0.007 ± 0.013] vs. [−0.006 ± 0.009]; respectively) were also significantly increased (p < 0.05).

FIGURE 4
www.frontiersin.org

Figure 4. Comparison of GluCEST% contrast in four brain regions in different groups. The Y-axis (GluCEST contrast at 3.0 ppm %) uses raw data. (A) (Inactive or Active) vs. HC. (B) (Acute or Chronic) vs. HC. *p < 0.05, **p < 0.01.

Microstructural alterations in TED patients by DKI

In the optic nerve, the values of Ka ([0.702 ± 0.168]) in active group was significantly lower than those in HCs ([0.834 ± 0.151]), while Kr in both active and chronic group ([1.541 ± 0.528], [1.495 ± 0.659], respectively) were significantly higher compared with those in HCs ([1.092 ± 0.374]). As comparison with HCs, FA ([0.438 ± 0.091] vs. [0.533 ± 0.093]) and Da ([0.701 ± 0.092] (um2/ms) vs. [0.789 ± 0.079]) (um2/ms) in OR in acute group were lower, and MD ([0.469 ± 0.061] (um2/ms)vs. [0.422 ± 0.042] (um2/ms)) and Dr. ([0.410 ± 0.068] (um2/ms)vs. [0.352 ± 0.045] (um2/ms)) in OL were higher.

Correlation analysis of metabolites with GluCEST and Grave’s disease (GD) associated hormones

Figure 5 showed that the GluCEST effect was positively correlated with Glu levels in four brain regions, including right optic radiation (ROR), left optic radiation (LOR), right occipital lobe (ROL) and left occipital lobe (LOL) in the acute group, with the R values of 0.554, 0.353, 0.596, 0.528, respectively. In the chronic group, the Gln levels in OR was positively correlated withTgAb (F = 0.909; p = 0.012), TPOAb (F = 0.873; p = 0.023), FT3 (F = 0.645; p = 0.032) and FT4 (F = 0.654; p = 0.029).

FIGURE 5
www.frontiersin.org

Figure 5. The correlation of the Glu levels in GluCEST and MRS in the acute group. The unit of Glu concentration (MRS) is in an arbitrary unit, the X-axis (GluCEST %) is raw data ×100%. (A): LOR, (B): ROR, (C): LOL, (D): ROL.

Discussion

Whether there are metabolic and microstructural changes in intracranial visual pathways in mild TED patients has not been reported currently. Altogether, our present study has been the first report so far by using 1H-MRS, GluCEST and DKI techniques to demonstrate alterations in the metabolism and microstructure in intracranial visual pathways in mild TED patients before the onset of DON. We found that damage to visual pathways occurs in mild TED cases, offering new ideas for DON’s diagnosis (Liu et al., 2023) and being of impact for identifying early DON mechanisms, which is a gradual and continuous spatio-emporal progression.

TED-associated metabolic changes by 1H-MRS and GluCEST

TCh levels were observed to increase by 1H-MRS in OR in the active and acute groups compared with HCs. It has been reported that the changes of Ch measured by MRS in glaucoma (Murphy et al., 2016; Sidek et al., 2016), and role of the cholinergic nervous system includes stimulating glutathione synthesis, preventing Glu excitotoxicity, protecting mitochondrial function to reduce oxidative damage and apoptosis (Faiq et al., 2019). Therefore, higher tCh levels in the active and acute groups may indicate a protective effect on improving the visual neuronal survival The changes of Ch may be related to the course of the disease. In our experiment, the level of Ch increased in the mild TED patients, but when the disease worsens in the later stage, it may be accompanied by undercompensation thus showing a decrease. Remarkably, their ROI was located in the occipital lobe, however, there was no statistical difference in Ch in the occipital lobe among all groups in our experiment. While in optic radiation, there was statistical difference in Ch, which may be related to the transmission order of the damage. The damage of the optic nerve was transmitted first to the optic radiation and then to the occipital lobe. Therefore, when studying early damage to the optic pathway, we could focus on changes in optic radiation, not just changes in the occipital lobe.

Compared with HC group, the amounts of Gln in OR in chronic group were significantly higher, together with a tendency increase of Glu, which might indicate chronic Glu-Gln cycle impairment in visual fibers over a TED course greater than 6 months. This Glu-Gln cycle sustains neural activity, and persistent disturbances of the Glu-Gln cycle flux may cause cognitive and affective symptoms in patients with Graves’ disease (Danielsen et al., 2008). Some other studies have suggested that visual processing depends on AMPA- and NMDA-type Glu receptors (Manookin et al., 2010). In patients with TED, increased intraorbital pressure may lead to impaired optic nerves. Therefore, the GluCEST effect in our study were significantly higher in the OR in the TED groups, indicating that increased Glu most likely represents damage to the OR and occipital lobe originating from the optic nerve (Kanaan et al., 2017). However, there was no significant difference in Glu levels between any two groups by 1H-MRS, although they showed a tendency increase in TED groups compared to HCs. Possible reason might be that the peak-overlap problem in 3.0 T 1H-MRS and partial volume effect reduce the accuracy of Glu quantification (Provencher, 1993). However, the GluCEST effect was significantly higher in TED groups and was positively correlated with Glu levels of the corresponding brain regions mentioned above, implying that GluCEST may be more sensitive than 1H-MRS to evaluate Glu levels, thanks for its high spatial-resolution imaging.

Correlation analysis of GD associated hormones and metabolites showed that changes of Gln levels in OR in chronic group were positively correlated with changes of serum TgAb, TPOAb, FT3, and FT4. Changes in serology may lead to changes in metabolites in visual pathways, which in true may indicate that the status of disease injury, which is a correlation with the dysregulation of the thyroid function, can be reflected by non-invasive detection of metabolites in the brain by 1H-MRS (Danielsen et al., 2008). However, the reasons behind this correlation are unclear. Whether serum hormones indirectly “communicate” with the brain through some mechanism and cause changes in brain metabolites remains to be further studied.

TED related microstructural changes measured by DKI

In terms of microstructural changes assessed by DKI, the kurtosis parameters of MK, MD, FA, Ka and Kr can be used as imaging biomarkers for assessing microstructural damage (Gong et al., 2013). Our study showed that FA and Da were lower in the OR and Dr. was lower in the OL in the acute group, indicating alterations in demyelination and increased axonal membrane permeability in both crossing and non-crossing fibers (Lu et al., 2020; Sun et al., 2020). The decrease of FA value needs DWI data-sets into NODDI as a complement to further distinguish the neurite density and fiber distribution direction of the tissue alternations.MK acquired from DKI was exhibited to be sensitive to the microstructul changes of lesions, such as in breast cancer reported by Tang et al. (Huang et al., 2019; Tang et al., 2022). However, we did not find significant alterations of MK in TED patients while FA was shown to be changed markedly, suggesting that TED patients may be characterized by changes in nerve fibers rather than local microstructure alterations. Previous studies have also suggested that FA of the OR is associated with visual sensitivity in the optic pathway (de Blank et al., 2013). Thus, the microstructure of the visual pathway may be altered before the onset of DON and FA may be more sensitive than visual-evoked potentials as an objectively measured indicator.

DKI has been suggested to be sensitive for detecting alterations in diffusion, and our results differed from previous DTI studies in TED patients, which may be due to the methodological differences between DTI and DKI acquisition, processing parameters and the influence of the partial-volume effects (Falangola et al., 2013). In contrast to previous findings, here changes in intraorbital optic nerve fibers were only found in Ka in the active group, while FA and MD showed only a slight and insignificant decreasing trend, most likely due to the intersection of axons in the optic chiasm (Zeng et al., 2018) and the movement of the intraorbital optic nerves with eyeball movements (Staempfli et al., 2007; Engelhorn et al., 2012).

Limitations

Our study had some limitations. First, the sample size in different TED groups was relatively small, thus using a larger sample with multiple TED types may yield a more accurate estimate. Second, this study was only limited to the cross-sectional design, which may bias our findings. Hence, continuous observation of the TED patients before and after treatment would be preferable. Third, correlation between the changes of serum hormones and brain metabolites is not clear, and the correlation between MRS and GluCEST may also have errors due to the size of ROI. Further study is needed to explore the association between imaging findings and hormones alterations.

Conclusion

To conclude, our study was the first report so far by using 1H-MRS, GluCEST and DKI techniques to demonstrate alterations in the metabolism and microstructure in intracranial visual pathways in TED patients before the onset of disabling dysthyroid optic neuropathy. GluCEST is more sensitive than 1H-MRS to monitor the Glu alterations in visual pathway in TED patients. The level of Gln is closely related to associated hormones alterations, indicating that disease injury status can be reflected through non-invasive metabolites detection by brain 1H-MRS. FA is the most sensitive DKI index of visual pathway impairment in TED patients. We found that damage to visual pathways occurs in mild TED cases, which not only offer a new approach to the diagnosis of DON, but also demonstrates neuropathy in TED is a gradual and continuous spatio-emporal progression. However, a multicenter prospective study with a larger cohort should be performed in near future to validate these results.

Data availability statement

The original contributions presented in the study are included in the article/supplementary materials, further inquiries can be directed to the corresponding author/s.

Ethics statement

The studies involving humans were approved by the Ethics Committee of Second Affiliated Hospital of Shantou University Medical College. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

LL: Conceptualization, Data curation, Investigation, Methodology, Software, Writing – original draft, Writing – review & editing. LZ: Data curation, Methodology, Writing – review & editing. HH: Methodology, Software, Writing – review & editing. JG: Conceptualization, Formal analysis, Investigation, Writing – review & editing. XZ: Data curation, Methodology, Software, Writing – review & editing. YL: Project administration, Resources, Writing – review & editing. RW: Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the National Science Foundation of China (31870981, 82020108016, 82071973), the Natural Science Foundation of Guangdong Province (2020A1515011022), the 2020 LKSF Cross-Disciplinary Research (2020LKSFBME06), the 2020 Li Ka Shing Foundation Cross-Disciplinary Research (2020LKSFG05D), and the Grant for Key Disciplinary Project of Clinical Medicine under the Guangdong High-Level University Development Program (002-18120302).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Chen, H. H., Hu, H., Chen, W., Cui, D., Xu, X. Q., Wu, F. Y., et al. (2020). Thyroid-associated orbitopathy: evaluating microstructural changes of extraocular muscles and optic nerves using readout-segmented Echo-planar imaging-based diffusion tensor imaging. Korean J. Radiol. 21, 332–340. doi: 10.3348/kjr.2019.0053

PubMed Abstract | CrossRef Full Text | Google Scholar

Danielsen, E. R., Elberling, T. V., Rasmussen, A. K., Dock, J., Hørding, M., Perrild, H., et al. (2008). Reduced parietooccipital white matter glutamine measured by proton magnetic resonance spectroscopy in treated graves' disease patients. J. Clin. Endocrinol. Metab. 93, 3192–3198. doi: 10.1210/jc.2007-2161

PubMed Abstract | CrossRef Full Text | Google Scholar

de Blank, P. M., Berman, J. I., Liu, G. T., Roberts, T. P., and Fisher, M. J. (2013). Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1. Neuro-Oncology 15, 1088–1095. doi: 10.1093/neuonc/not068

PubMed Abstract | CrossRef Full Text | Google Scholar

Elberling, T. V., Danielsen, E. R., Rasmussen, A. K., Feldt-Rasmussen, U., Waldemar, G., and Thomsen, C. (2003). Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves' disease. Neurology 60, 142–145. doi: 10.1212/01.WNL.0000038911.07643.BF

PubMed Abstract | CrossRef Full Text | Google Scholar

Engelhorn, T., Michelson, G., Waerntges, S., Hempel, S., El-Rafei, A., Struffert, T., et al. (2012). A new approach to assess intracranial white matter abnormalities in glaucoma patients: changes of fractional anisotropy detected by 3T diffusion tensor imaging. Acad. Radiol. 19, 485–488. doi: 10.1016/j.acra.2011.12.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Faiq, M. A., Wollstein, G., Schuman, J. S., and Chan, K. C. (2019). Cholinergic nervous system and glaucoma: from basic science to clinical applications. Prog. Retin. Eye Res. 72:100767. doi: 10.1016/j.preteyeres.2019.06.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Falangola, M. F., Jensen, J. H., Tabesh, A., Hu, C., Deardorff, R. L., Babb, J. S., et al. (2013). Non-gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease. Magn. Reson. Imaging 31, 840–846. doi: 10.1016/j.mri.2013.02.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Garip-Kuebler, A., Halfter, K., Reznicek, L., Klingenstein, A., Priglinger, S., and Hintschich, C. J. T. B. J. O. O. (2021). Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy. Br. J. Ophthalmol. 105, 1019–1023. doi: 10.1136/bjophthalmol-2020-316433

PubMed Abstract | CrossRef Full Text | Google Scholar

Gong, N. J., Wong, C. S., Chan, C. C., Leung, L. M., and Chu, Y. C. (2013). Correlations between microstructural alterations and severity of cognitive deficiency in Alzheimer's disease and mild cognitive impairment: a diffusional kurtosis imaging study. Magn. Reson. Imaging 31, 688–694. doi: 10.1016/j.mri.2012.10.027

PubMed Abstract | CrossRef Full Text | Google Scholar

Guan, J., Ma, X., Geng, Y., Qi, D., Shen, Y., Shen, Z., et al. (2019). Diffusion kurtosis imaging for detection of early brain changes in Parkinson's disease. Front. Neurol. 10:1285. doi: 10.3389/fneur.2019.01285

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, Y., Lin, Y., Hu, W., Ma, C., Lin, W., Wang, Z., et al. (2019). Diffusion kurtosis at 3.0T as an in vivo imaging marker for breast cancer characterization: correlation with prognostic factors. J magnetic resonance imaging: JMRI 49, 845–856. doi: 10.1002/jmri.26249

PubMed Abstract | CrossRef Full Text | Google Scholar

Ji, X., Xiao, W., Ye, H., Chen, R., Wu, J., Mao, Y., et al. (2021). Ultrasonographic measurement of the optic nerve sheath diameter in dysthyroid optic neuropathy. Eye (Lond.) 35, 568–574. doi: 10.1038/s41433-020-0904-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Jia, Y., Chen, Y., Geng, K., Cheng, Y., Li, Y., Qiu, J., et al. (2020). Glutamate chemical exchange saturation transfer (GluCEST) magnetic resonance imaging in pre-clinical and clinical applications for encephalitis. Front. Neurosci. 14:750. doi: 10.3389/fnins.2020.00750

PubMed Abstract | CrossRef Full Text | Google Scholar

Kanaan, A. S., Gerasch, S., García-García, I., Lampe, L., Pampel, A., Anwander, A., et al. (2017). Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome. Brain J. Neurol. 140, 218–234. doi: 10.1093/brain/aww285

PubMed Abstract | CrossRef Full Text | Google Scholar

Lee, H., Lee, Y. H., Suh, S. I., Jeong, E. K., Baek, S., and Seo, H. S. (2018). Characterizing Intraorbital optic nerve changes on diffusion tensor imaging in thyroid eye disease before dysthyroid optic neuropathy. J. Comput. Assist. Tomogr. 42, 293–298. doi: 10.1097/RCT.0000000000000680

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, T., Qu, X., Chen, W., Wang, Q., Wang, H., Wang, Y., et al. (2020). Altered information flow and microstructure abnormalities of visual cortex in normal-tension glaucoma: evidence from resting-state fMRI and DKI. Brain Res. 1741:146874. doi: 10.1016/j.brainres.2020.146874

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, P., Luo, B., Chen, L., Wang, Q., Zhai, L., Wu, H., et al. (2023). Preliminary diffusion-tensor imaging evidence for trans-synaptic axonal degeneration in dysthyroid optic neuropathy due to thyroid-associated ophthalmopathy. J mag resonance imaging: JMRI 57, 834–844. doi: 10.1002/jmri.28352

PubMed Abstract | CrossRef Full Text | Google Scholar

Lu, P., Yuan, T., Liu, X., Tian, G., Zhang, J., and Sha, Y. (2020). Role of diffusional kurtosis imaging in differentiating neuromyelitis Optica-related and multiple sclerosis-related acute optic neuritis: comparison with diffusion-weighted imaging. J. Comput. Assist. Tomogr. 44, 47–52. doi: 10.1097/RCT.0000000000000974

PubMed Abstract | CrossRef Full Text | Google Scholar

Manookin, M. B., Weick, M., Stafford, B. K., and Demb, J. B. (2010). NMDA receptor contributions to visual contrast coding. Neuron 67, 280–293. doi: 10.1016/j.neuron.2010.06.020

PubMed Abstract | CrossRef Full Text | Google Scholar

Mao, Y., Zhuang, Z., Chen, Y., Zhang, X., Shen, Y., Lin, G., et al. (2019). Imaging of glutamate in acute traumatic brain injury using chemical exchange saturation transfer. Quant. Imaging Med. Surg. 9, 1652–1663. doi: 10.21037/qims.2019.09.08

PubMed Abstract | CrossRef Full Text | Google Scholar

Mehrabian, H., Desmond, K. L., Soliman, H., Sahgal, A., and Stanisz, G. J. (2017). Differentiation between radiation necrosis and tumor progression using chemical exchange saturation transfer. Clin. Cancer Res. 23, 3667–3675. doi: 10.1158/1078-0432.CCR-16-2265

PubMed Abstract | CrossRef Full Text | Google Scholar

Murphy, M. C., Conner, I. P., Teng, C. Y., Lawrence, J. D., Safiullah, Z., Wang, B., et al. (2016). Retinal structures and visual cortex activity are impaired prior to clinical vision loss in glaucoma. Sci. Rep. 6:31464. doi: 10.1038/srep31464

PubMed Abstract | CrossRef Full Text | Google Scholar

Provencher, S. W. (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30, 672–679. doi: 10.1002/mrm.1910300604

PubMed Abstract | CrossRef Full Text | Google Scholar

Riguetto, C. M., Neto, A. M., Tambascia, M. A., and Zantut-Wittmann, D. E. (2019). The relationship between quality of life, cognition, and thyroid status in Graves' disease. Endocrine 63, 87–93. doi: 10.1007/s12020-018-1733-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Rutkowska-Hinc, B., Maj, E., Jabłońska, A., Milczarek-Banach, J., Bednarczuk, T., and Miśkiewicz, P. (2018). Prevalence of radiological signs of dysthyroid optic neuropathy in magnetic resonance imaging in patients with active, moderate-to-severe, and very severe graves orbitopathy. European thyroid journal 7, 88–94. doi: 10.1159/000486828

PubMed Abstract | CrossRef Full Text | Google Scholar

Sidek, S., Ramli, N., Rahmat, K., Ramli, N. M., Abdulrahman, F., and Kuo, T. L. (2016). In vivo proton magnetic resonance spectroscopy (1H-MRS) evaluation of the metabolite concentration of optic radiation in primary open angle glaucoma. Eur. Radiol. 26, 4404–4412. doi: 10.1007/s00330-016-4279-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Smith, T. J., and Hegedüs, L. (2016). Graves' disease. N. Engl. J. Med. 375, 1552–1565. doi: 10.1056/NEJMra1510030

CrossRef Full Text | Google Scholar

Staempfli, P., Rienmueller, A., Reischauer, C., Valavanis, A., Boesiger, P., and Kollias, S. (2007). Reconstruction of the human visual system based on DTI fiber tracking. Journal of magnetic resonance imaging: JMRI 26, 886–893. doi: 10.1002/jmri.21098

PubMed Abstract | CrossRef Full Text | Google Scholar

Sun, Z., Parra, C., Bang, J.W., Fieremans, E., Wollstein, G., Schuman, J.S., et al. Diffusion kurtosis imaging reveals optic tract damage that correlates with clinical severity in glaucoma. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference (2020) (2020) 1746–1749, doi: 10.1109/EMBC44109.2020.9176192

PubMed Abstract | CrossRef Full Text | Google Scholar

Sydnor, V. J., Larsen, B., Kohler, C., Crow, A. J. D., Rush, S. L., Calkins, M. E., et al. (2021). Diminished reward responsiveness is associated with lower reward network Glu CEST: an ultra-high field glutamate imaging study. Mol. Psychiatry 26, 2137–2147. doi: 10.1038/s41380-020-00986-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Tang, Y., Xiao, G., Shen, Z., Zhuang, C., Xie, Y., Zhang, X., et al. (2020). Noninvasive detection of extracellular pH in human benign and malignant liver Tumors using CEST MRI. Front. Oncol. 10:578985. doi: 10.3389/fonc.2020.578985

PubMed Abstract | CrossRef Full Text | Google Scholar

Tang, W., Zhou, H., Quan, T., Chen, X., Zhang, H., Lin, Y., et al. (2022). XGboost prediction model based on 3.0T diffusion kurtosis imaging improves the diagnostic accuracy of MRI BiRADS 4 masses. Front. Oncol. 12:833680. doi: 10.3389/fonc.2022.833680

PubMed Abstract | CrossRef Full Text | Google Scholar

Taylor, P. N., Zhang, L., Lee, R. W. J., Muller, I., Ezra, D. G., Dayan, C. M., et al. (2020). New insights into the pathogenesis and nonsurgical management of graves orbitopathy. Nat. Rev. Endocrinol. 16, 104–116. doi: 10.1038/s41574-019-0305-4

CrossRef Full Text | Google Scholar

Tur, C., Goodkin, O., Altmann, D. R., Jenkins, T. M., Miszkiel, K., Mirigliani, A., et al. (2016). Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis. Brain J. Neurol. 139, 816–828. doi: 10.1093/brain/awv396

CrossRef Full Text | Google Scholar

Xu, Z. F., Sun, J. S., Zhang, X. H., Feng, Y. Y., Pan, A. Z., Gao, M. Y., et al. (2018). Microstructural visual pathway abnormalities in patients with primary glaucoma: 3 T diffusion kurtosis imaging study. Clin. Radiol. 73, e9–591.e15. doi: 10.1016/j.crad.2018.01.010

CrossRef Full Text | Google Scholar

Zeng, C., Du, S., Han, Y., Fu, J., Luo, Q., Xiang, Y., et al. (2018). Optic radiations are thinner and show signs of iron deposition in patients with long-standing remitting-relapsing multiple sclerosis: an enhanced T (2)(*)-weighted angiography imaging study. Eur. Radiol. 28, 4447–4454. doi: 10.1007/s00330-018-5461-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, T., Li, M., Xiao, W., Ye, H., Chen, R., Yuan, J., et al. (2021). Bulbar conjunctival microvascular alterations in thyroid-associated ophthalmopathy patients with different activities. Curr. Eye Res. 46, 943–948. doi: 10.1080/02713683.2020.1849729

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, T., Xiao, W., Ye, H., Chen, R., Mao, Y., and Yang, H. (2019). Peripapillary and macular vessel density in dysthyroid optic neuropathy: an optical coherence tomography angiography study. Invest. Ophthalmol. Vis. Sci. 60, 1863–1869. doi: 10.1167/iovs.18-25941

CrossRef Full Text | Google Scholar

Keywords: visual pathways, thyroid eye disease, magnetic resonance spectroscopy, glutamate chemical exchange saturation transfer, diffusion kurtosis imaging

Citation: Luo L, Zhang L, Huang H, Guan J, Zhang X, Lin Y and Wu R (2024) 3.0 T multi-parametric MRI reveals metabolic and microstructural abnormalities in the posterior visual pathways in patients with thyroid eye disease. Front. Neurosci. 17:1306364. doi: 10.3389/fnins.2023.1306364

Received: 03 October 2023; Accepted: 22 December 2023;
Published: 09 January 2024.

Edited by:

Linlin Shen, Shenzhen University, China

Reviewed by:

Hideto Kuribayashi, Siemens Healthcare K.K., Japan
Zhiwei Shen, Philips Healthcare, China

Copyright © 2024 Luo, Zhang, Huang, Guan, Zhang, Lin and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yan Lin, 994809889@qq.com; Renhua Wu, rhwu@stu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.